ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

NCI To Fund Two Construction Grants With 42 Million From Special NIH Fund

March 2, 1990

Treatment IND or GM-CSF Is Approved

October 5, 1990

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989